ClinStar Webinar to Address How to Leverage Russia and Ukraine in Your Risk Management and Rescue Study Planning

<0> Vice President Operations Richard Koenig to Present on Value of Including Russia and Ukraine in Your Initial Global Clinical Study Plans and at a Minimum in Your Risk Management and Rescue Study Plans </0>

ClinStar Webinar to Address How to Leverage Russia and Ukraine in Your Risk Management and Rescue Study Planning

ClinStar, LLCHeather Newbold, 919-354-3573 ext. 276

, an established clinical research organization providing clinical development services in the emerging markets of Russia and Eastern Europe to the pharmaceutical and biotechnology industry, announced today that they will host a live webinar November 8, 2012 entitled, ".”

“Risk Management is one of the fundamentals of good project management and lagging enrollment is one of the key risks for any clinical trial. It can damage many other key risk areas including: schedule, budget, and quality. Unfortunately, many contingency plans inadequately address enrollment risks because they seek minor changes to existing strategies, rather than new approaches to impending threats,” says Vice President Operations Richard Koenig. “With markets in the West saturated with clinical trials and patient enrollment and retention more challenging than ever, the industry is embracing emerging markets to take advantage of faster enrollment rates and lower drop-out rates.”

During the webinar, Mr. Koenig will discuss the enormous value and practical considerations of including Russia in your initial global clinical study planning, and minimally, in your risk management and contingency planning. If you didn’t include Russia in your study or risk management plans from the outset, however, Mr. Koenig will examine how you can leverage Russia and Ukraine in your study rescue planning. Specifically, he will evaluate the critical elements required for a successful study transition plan, including regulatory tasks, drug storage, clinical management and investigator payments.

ClinStar is one of the most prominent clinical research organizations in the emerging markets of Eastern Europe and the Baltics with more than 10 years of expertise in Phase I-IV clinical development in multiple therapeutic areas. Headquartered in San Francisco, California, ClinStar manages clinical trials from its offices in Russia, Ukraine and Belarus, with total staff of over 260 people. Its portfolio contains over 130 clinical trials conducted for US and European pharmaceutical and biotechnology companies. More information is available at .

Suggested Articles

Almirall and Iktos will use the latter's AI technology to design new compounds that tick multiple drug criteria boxes.

Pfizer’s 2017 spinout company SpringWorks has lost president and founder Lara Sullivan, M.D., who has moved over to Pyxis Oncology as its new chief.

In this week's EuroBiotech Report, Sanofi inks $2.5B Synthorx takeover and posts sutimlimab data, Roche shares bispecific results and more.